| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acute deterioration of Charcot–Marie–Tooth disease IA (CMT IA) following 2 mg of vincristine chemotherapy
|
Hildebrandt, G.
|
|
2000
|
11 |
6 |
p. 743-747
|
artikel
|
| 2 |
Acute deterioration of Charcot-Marie-Tooth disease IA (CMTIA) following 2 mg of vincristine chemotherapy
|
Hildebrandt, G.
|
|
|
11 |
6 |
p. 743-747
|
artikel
|
| 3 |
A dose-finding study of liposomal daunorubicin with CVP (COP-X) in advanced NHL
|
Flinn, I. W.
|
|
2000
|
11 |
6 |
p. 691-695
|
artikel
|
| 4 |
A dose-finding study of liposomal daunorubicin with CVP (COP-X) in advanced NHL
|
Flinn, I.W.
|
|
|
11 |
6 |
p. 691-695
|
artikel
|
| 5 |
African Organisation for Research and Training in Cancer (AORTIC) to be reactivated
|
|
|
|
11 |
6 |
p. 638-639
|
artikel
|
| 6 |
A phase I–II study of concomitant chemoradiotherapy with paclitaxel (one-hour infusion), 5-fluorouracil and hydroxyurea with granulocyte colony stimulating factor support for patients with poor prognosis head and neck cancer
|
Brockstein, B.
|
|
2000
|
11 |
6 |
p. 721-728
|
artikel
|
| 7 |
A phase I–II study of concomitant chemoradiotherapy with paclitaxel (one-hour infusion), 5-fluorouracil and hydroxyurea with granulocyte colony stimulating factor support for patients with poor prognosis head and neck cancer
|
Brockstein, B.
|
|
|
11 |
6 |
p. 721-728
|
artikel
|
| 8 |
Awards, appointments
|
|
|
|
11 |
6 |
p. 641
|
artikel
|
| 9 |
Book review
|
Calderoni, A.
|
|
|
11 |
6 |
p. 644
|
artikel
|
| 10 |
Book review
|
Midgley, R.
|
|
|
11 |
6 |
p. 764
|
artikel
|
| 11 |
Caelyx™ in malignant mesothelioma: A phase II EORTC study
|
Baas, P.
|
|
|
11 |
6 |
p. 697-700
|
artikel
|
| 12 |
CaelyxTM in malignant mesothelioma: A phase II EORTC study
|
Baas, P.
|
|
2000
|
11 |
6 |
p. 697-700
|
artikel
|
| 13 |
Contents of the next issue
|
|
|
|
11 |
6 |
p. vi
|
artikel
|
| 14 |
Copyright
|
|
|
|
11 |
6 |
p. iv
|
artikel
|
| 15 |
Corrigendum
|
|
|
|
11 |
6 |
p. 765
|
artikel
|
| 16 |
CPT-11 approved, oxaliplatin rejected by FDA
|
|
|
|
11 |
6 |
p. 640
|
artikel
|
| 17 |
Editorial Board
|
|
|
|
11 |
6 |
p. v
|
artikel
|
| 18 |
Fight over Taxol patents erupts
|
|
|
|
11 |
6 |
p. 641
|
artikel
|
| 19 |
Health spending in UK to rise: How much will there be for cancer?
|
|
|
|
11 |
6 |
p. 639
|
artikel
|
| 20 |
High-dose BEAM chemotherapy with autologous peripheral blood progenitor-cell transplantation for unselected patients with primary refractory or relapsed Hodgkin's disease
|
Argiris, A.
|
|
2000
|
11 |
6 |
p. 665-672
|
artikel
|
| 21 |
High-dose BEAM chemotherapy with autologous peripheral blood progenitor-cell transplantation for unselected patients with primary refractory or relapsed Hodgkin's disease
|
Argiris, A.
|
|
|
11 |
6 |
p. 665-672
|
artikel
|
| 22 |
Incidence and risk factors of central nervous system relapse in histologically aggressive non-Hodgkin's lymphoma uniformly treated and receiving intrathecal central nervous system prophylaxis: A GELA study on 974 patients
|
Haioun, C.
|
|
2000
|
11 |
6 |
p. 685-690
|
artikel
|
| 23 |
Incidence and risk factors of central nervous system relapse in histologically aggressive non-Hodgkin's lymphoma uniformly treated and receiving intrathecal central nervous system prophylaxis: A GELA study on 974 patients
|
Haioun, C.
|
|
|
11 |
6 |
p. 685-690
|
artikel
|
| 24 |
In this issue
|
|
|
|
11 |
6 |
p. vi
|
artikel
|
| 25 |
Malignant peritoneal mesothelioma treated by continuous hyperthermic peritoneal perfusion chemotherapy
|
de Bree, E.
|
|
2000
|
11 |
6 |
p. 753-756
|
artikel
|
| 26 |
Malignant peritoneal mesothelioma treated by continuous hyperthermic peritoneal perfusion chemotherapy
|
de Bree, E.
|
|
|
11 |
6 |
p. 753-756
|
artikel
|
| 27 |
Management of relapsed Hodgkin's disease patients with high-dose chemotherapy and marrow stem-cell transplantation
|
Armitage, J. O.
|
|
2000
|
11 |
6 |
p. 645-646
|
artikel
|
| 28 |
Management of relapsed Hodgkin's disease patients with high-dose chemotherapy and marrow stem-cell transplantation
|
Armitage, J.O.
|
|
|
11 |
6 |
p. 645-646
|
artikel
|
| 29 |
M. Bernstein, M. S. Berger (eds)., Neuro-Oncology – The Essentials
|
Calderoni, A.
|
|
2000
|
11 |
6 |
p. 644
|
artikel
|
| 30 |
Metastatic extragonadal seminoma associated with cardiac transplantation
|
de Bono, J. S.
|
|
2000
|
11 |
6 |
p. 749-752
|
artikel
|
| 31 |
Metastatic extragonadal seminoma associated with cardiac transplantation
|
de Bono, J.S.
|
|
|
11 |
6 |
p. 749-752
|
artikel
|
| 32 |
M. H. Bronchud, M. Foote, W. P. Peters et al. (eds)., Principles of Molecular Oncology
|
Midgley, R.
|
|
2000
|
11 |
6 |
p. 764
|
artikel
|
| 33 |
M. Sieber, U. Rüffer, A. Josting & V. Diehl. Treatment of Hodgkin's disease: Current strategies of the German Hodgkin's Lymphoma Study Group. Ann Oncol 1999; 10 (Suppl 6): S23–S29
|
|
|
2000
|
11 |
6 |
p. 765
|
artikel
|
| 34 |
Multicenter phase II trial of docetaxel and carboplatin in patients with stage IIIB and IV non-small-cell lung cancer
|
Belani, C. P.
|
|
2000
|
11 |
6 |
p. 673-678
|
artikel
|
| 35 |
Multicenter phase II trial of docetaxel and carboplatin in patients with stage IIIB and IV non-small-cell lung cancer
|
Belani, C.P.
|
|
|
11 |
6 |
p. 673-678
|
artikel
|
| 36 |
Patterns of relapse and subsequent management following high-dose chemotherapy with autologous haematopoietic support in relapsed or refractory Hodgkin's lymphoma: A two centre study
|
Shamash, J.
|
|
2000
|
11 |
6 |
p. 715-719
|
artikel
|
| 37 |
Patterns of relapse and subsequent management following high-dose chemotherapy with autologous haematopoietic support in relapsed or refractory Hodgkin's lymphoma: A two centre study
|
Shamash, J.
|
|
|
11 |
6 |
p. 715-719
|
artikel
|
| 38 |
Perhaps not everyone knows that…
|
|
|
|
11 |
6 |
p. 641-643
|
artikel
|
| 39 |
Phase II trial of low-dose cyclophosphamide, leucovorin, high-dose 5-fluorouracil 24-hour continuous infusion and tamoxifen in advanced biliary tract cancer
|
Eckel, F.
|
|
2000
|
11 |
6 |
p. 762-763
|
artikel
|
| 40 |
Phase II trial of low-dose cyclo-phosphamide, leucovorin, high-dose 5-fluorouracil 24-hour continuous infusion and tamoxifen in advanced biliary tract cancer
|
Eckel, F.
|
|
|
11 |
6 |
p. 762-763
|
artikel
|
| 41 |
Phase I open study of the effects of ascending doses of the cytotoxic immunoconjugate CMB-401 (hCTMO1-calicheamicin) in patients with epithelial ovarian cancer
|
Gillespie, A. M.
|
|
2000
|
11 |
6 |
p. 735-741
|
artikel
|
| 42 |
Phase I open study of the effects of ascending doses of the cytotoxic immunoconjugate CMB-401 (hCTMO1-calicheamicin) in patients with epithelial ovarian cancer
|
Gillespie, A.M.
|
|
|
11 |
6 |
p. 735-741
|
artikel
|
| 43 |
Salvage treatment of advanced non-small-cell lung cancer previously treated with docetaxel-based front-line chemotherapy with irinotecan (CPT-11) in combination with cisplatin
|
Kakolyris, S.
|
|
2000
|
11 |
6 |
p. 757-760
|
artikel
|
| 44 |
Salvage treatment of advanced non-small-cell lung cancer previously treated with docetaxel-based front-line chemotherapy with irinotecan (CPT-11) in combination with cisplatin
|
Kakolyris, S.
|
|
|
11 |
6 |
p. 757-760
|
artikel
|
| 45 |
Semen analysis and cryoconservation before treatment in Hodgkin's disease
|
Fitoussi, O.
|
|
2000
|
11 |
6 |
p. 679-684
|
artikel
|
| 46 |
Semen analysis and cryoconservation before treatment in Hodgkin's disease
|
Fitoussi, O.
|
|
|
11 |
6 |
p. 679-684
|
artikel
|
| 47 |
Sentinel node biopsy as a practical alternative to axillary lymph node dissection in breast cancer patients: An approach to its validity
|
Fraile, M.
|
|
2000
|
11 |
6 |
p. 701-705
|
artikel
|
| 48 |
Sentinel node biopsy as a practical alternative to axillary lymph node dissection in breast cancer patients: An approach to its validity
|
Fraile, M.
|
|
|
11 |
6 |
p. 701-705
|
artikel
|
| 49 |
Serum endostatin levels in patients with hepatocellular carcinoma
|
Yamagata, M.
|
|
2000
|
11 |
6 |
p. 761-762
|
artikel
|
| 50 |
Serum endostatin levels in patients with hepatocellular carcinoma
|
Yamagata, M.
|
|
|
11 |
6 |
p. 761-762
|
artikel
|
| 51 |
Table of Contents
|
|
|
|
11 |
6 |
p. iii-iv
|
artikel
|
| 52 |
The contribution of molecular markers to the prediction of response in the treatment of breast cancer: A review of the literature on HER-2, p53and BCL-2
|
Hamilton, A.
|
|
2000
|
11 |
6 |
p. 647-663
|
artikel
|
| 53 |
The contribution of molecular markers to the prediction of response in the treatment of breast cancer: A review of the literature on HER-2, p53 and BCL-2
|
Hamilton, A.
|
|
|
11 |
6 |
p. 647-663
|
artikel
|
| 54 |
The interferon-α regulation of interferon regulatory factor 1 (IRF-1) and IRF-2 has therapeutic implications in carcinoid tumors
|
Zhou, Y.
|
|
2000
|
11 |
6 |
p. 707-714
|
artikel
|
| 55 |
The interferon-α regulation of interferon regulatory factor 1 (IRF-1) and IRF-2 has therapeutic implications in carcinoid tumors
|
Zhou, Y.
|
|
|
11 |
6 |
p. 707-714
|
artikel
|
| 56 |
The International Network for Cancer Treatment and Research (INCTR)
|
|
|
|
11 |
6 |
p. 637-638
|
artikel
|
| 57 |
The International Network for Cancer Treatment and Research (INCTR); African Organisation for Research and Training in Cancer (AORTIC) to be reactivated; Health spending in UK to rise: How much will there be for cancer-; Veronesi Minister of Health in Italy; CPT-11 approved, oxaliplatin rejected by FDA; Fight over Taxol patents erupts; Awards, appointments; Perhaps not everyone knows that...
|
|
|
2000
|
11 |
6 |
p. 637-643
|
artikel
|
| 58 |
Veronesi Minister of Health in Italy
|
|
|
|
11 |
6 |
p. 639-640
|
artikel
|
| 59 |
Weekly administration of bendamustine: A phase I study in patients with advanced progressive solid tumours
|
Schöffski, P.
|
|
2000
|
11 |
6 |
p. 729-734
|
artikel
|
| 60 |
Weekly administration of bendamustine: A phase I study in patients with advanced progressive solid tumours
|
Schöffski, P.
|
|
|
11 |
6 |
p. 729-734
|
artikel
|
Tijdschrift beschrijving